학술논문

Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, March 2023, 72(3):775-782)
Subject
Language
English
ISSN
14320851
03407004